Sign In

Login

Password

Forgot Password ? Sign Up

Clostridioides difficile (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Clostridioides difficile" in German language version.

refsWebsite
Global rank German rank
13doi.org
2nd place
3rd place
9zdb-katalog.de
123rd place
6th place
9rki.de
4,845th place
310th place
6web.archive.org
1st place
1st place
6redirecter.toolforge.org
33rd place
2nd place
6IABotmemento.invalid
low place
low place
6nih.gov
4th place
7th place
2aerzteblatt.de
3,043rd place
200th place
2mdpi.com
2,912th place
1,242nd place
1aerztezeitung.at
low place
6,639th place
1oup.com
485th place
715th place
1sciencedirect.com
149th place
298th place
1cbc.ca
115th place
466th place
1thelancet.com
2,393rd place
2,660th place
1uni-koeln.de
2,455th place
501st place
1akdae.de
low place
1,853rd place
1arznei-news.de
low place
low place
1spiegel.de
66th place
4th place
1theguardian.com
12th place
25th place
1wissenschaft-online.de
low place
2,288th place
1bbc.co.uk
8th place
37th place
1dradio.de
4,066th place
262nd place
1orf.at
418th place
22nd place
1sachsen.de
2,508th place
228th place

IABotmemento.invalid (Global: low place; German: low place)

aerzteblatt.de (Global: 3,043rd place; German: 200th place)

aerztezeitung.at (Global: low place; German: 6,639th place)

  • Franz Allerberger u. a.: Clostridium difficile-Infektion. In: Österreichische Ärztezeitung. Nr. 5, 10. März 2014 (aerztezeitung.at [PDF]).

akdae.de (Global: low place; German: 1,853rd place)

arznei-news.de (Global: low place; German: low place)

  • Christian Hilscher: Ridinilazol. In: Arznei-News. 8. März 2016, abgerufen am 8. November 2022.

bbc.co.uk (Global: 8th place; German: 37th place)

news.bbc.co.uk

cbc.ca (Global: 115th place; German: 466th place)

doi.org (Global: 2nd place; German: 3rd place)

  • Michael B. Francis, Charlotte A. Allen, Ritu Shrestha, Joseph A. Sorg: Bile Acid Recognition by the Clostridium difficile Germinant Receptor, CspC, Is Important for Establishing Infection. In: PLOS Pathogens. Band 9, Nr. 5, 5. September 2013, ISSN 1553-7374, S. e1003356, doi:10.1371/journal.ppat.1003356, PMID 23675301, PMC 3649964 (freier Volltext).
  • Thomas Jank, Torsten Giesemann, Klaus Aktories: Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. In: Glycobiology. Band 17, Nr. 4, 1. April 2007, ISSN 1460-2423, S. 15R–22R, doi:10.1093/glycob/cwm004 (oup.com [abgerufen am 4. Dezember 2020]).
  • Vincent B. Young: Vaccinating against Clostridioides difficile Infection 2025, Band 392, Ausgabe 12 vom 27. März 2025, Seiten 1237–1240, DOI: 10.1056/NEJMcibr2413794
  • Stefano Di Bella, Paolo Ascenzi, Steven Siarakas, Nicola Petrosillo, Alessandra di Masi: Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects. In: Toxins. Band 8, Nr. 5, 3. Mai 2016, ISSN 2072-6651, S. 134, doi:10.3390/toxins8050134, PMID 27153087, PMC 4885049 (freier Volltext) – (mdpi.com [abgerufen am 28. Oktober 2023]).
  • Federica Tonon, Stefano Di Bella, Gabriele Grassi, Roberto Luzzati, Paolo Ascenzi, Alessandra di Masi, Cristina Zennaro: Extra-Intestinal Effects of C. difficile Toxin A and B: An In Vivo Study Using the Zebrafish Embryo Model. In: Cells. Band 9, Nr. 12, 1. Dezember 2020, ISSN 2073-4409, S. 2575, doi:10.3390/cells9122575, PMID 33271969, PMC 7760802 (freier Volltext) – (mdpi.com [abgerufen am 28. Oktober 2023]).
  • Klaus Aktories, Panagiotis Papatheodorou, Carsten Schwan: Binary Clostridium difficile toxin (CDT) – A virulence factor disturbing the cytoskeleton. In: Anaerobe (= ClostPath 2017: 10th International Conference on the Molecular Biology and Pathogenesis of the Clostridia). Band 53, 1. Oktober 2018, ISSN 1075-9964, S. 21–29, doi:10.1016/j.anaerobe.2018.03.001 (sciencedirect.com [abgerufen am 4. Dezember 2020]).
  • Tor C Savidge, Petri Urvil, Numan Oezguen, Kausar Ali, Aproteem Choudhury: Host S-nitrosylation inhibits clostridial small molecule–activated glucosylating toxins. In: Nature Medicine. 2011. doi:10.1038/nm.2405.
  • Keeley O’Grady, Daniel R. Knight, Thomas V. Riley: Antimicrobial resistance in Clostridioides difficile. In: European Journal of Clinical Microbiology & Infectious Diseases. Band 40, Nr. 12, 1. Dezember 2021, ISSN 1435-4373, S. 2459–2478, doi:10.1007/s10096-021-04311-5.
  • E. van Nood, A. Vrieze, M. Nieuwdorp, S. Fuentes, E. G. Zoetendal, W. M. de Vos, C. E. Visser, E. J. Kuijper, J. F. W. M. Bartelsman, J. P. G. Tijssen, P. Speelman, M. G. W. Dijkgraaf, J. J. Keller: Duodenal. Infusion of Donor Feces for Recurrent Clostridium difficile. In: NEJM. doi:10.1056/NEJMoa1205037.
  • Deirdre A Collins, Thomas V. Riley: Ridinilazole: a novel, narrow‐spectrum antimicrobial agent targeting Clostridium ( Clostridioides ) difficile. In: Letters in Applied Microbiology. Band 75, Nr. 3, September 2022, ISSN 0266-8254, S. 526–536, doi:10.1111/lam.13664, PMID 35119124, PMC 9541751 (freier Volltext).
  • A. Howerton, M. Patra, E. Abel-Santos: A new strategy for the prevention of Clostridium difficile infection. In: The Journal of infectious diseases. Band 207, Nummer 10, Mai 2013, S. 1498–1504, ISSN 1537-6613. doi:10.1093/infdis/jit068. PMID 23420906.
  • Daniel Paredes-Sabja, Glenda Cofre-Araneda, Christian Brito-Silva, Marjorie Pizarro-Guajardo, Mahfuzur R. Sarker: Clostridium difficile Spore-Macrophage Interactions: Spore Survival. In: PLOS ONE. Band 7, Nr. 8, 27. August 2012, ISSN 1932-6203, S. e43635, doi:10.1371/journal.pone.0043635, PMID 22952726, PMC 3428350 (freier Volltext).
  • I. Adlerberth, H. Huang, E. Lindberg, N. Aberg, B. Hesselmar, R. Saalman, C. E. Nord, A. E. Wold, A. Weintraub: Toxin-producing Clostridium difficile strains as long-term gut colonizers of healthy infants. In: Journal of Clinical Microbiology. doi:10.1128/JCM.01701-13.

dradio.de (Global: 4,066th place; German: 262nd place)

mdpi.com (Global: 2,912th place; German: 1,242nd place)

  • Stefano Di Bella, Paolo Ascenzi, Steven Siarakas, Nicola Petrosillo, Alessandra di Masi: Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects. In: Toxins. Band 8, Nr. 5, 3. Mai 2016, ISSN 2072-6651, S. 134, doi:10.3390/toxins8050134, PMID 27153087, PMC 4885049 (freier Volltext) – (mdpi.com [abgerufen am 28. Oktober 2023]).
  • Federica Tonon, Stefano Di Bella, Gabriele Grassi, Roberto Luzzati, Paolo Ascenzi, Alessandra di Masi, Cristina Zennaro: Extra-Intestinal Effects of C. difficile Toxin A and B: An In Vivo Study Using the Zebrafish Embryo Model. In: Cells. Band 9, Nr. 12, 1. Dezember 2020, ISSN 2073-4409, S. 2575, doi:10.3390/cells9122575, PMID 33271969, PMC 7760802 (freier Volltext) – (mdpi.com [abgerufen am 28. Oktober 2023]).

nih.gov (Global: 4th place; German: 7th place)

ncbi.nlm.nih.gov

  • Michael B. Francis, Charlotte A. Allen, Ritu Shrestha, Joseph A. Sorg: Bile Acid Recognition by the Clostridium difficile Germinant Receptor, CspC, Is Important for Establishing Infection. In: PLOS Pathogens. Band 9, Nr. 5, 5. September 2013, ISSN 1553-7374, S. e1003356, doi:10.1371/journal.ppat.1003356, PMID 23675301, PMC 3649964 (freier Volltext).
  • Stefano Di Bella, Paolo Ascenzi, Steven Siarakas, Nicola Petrosillo, Alessandra di Masi: Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects. In: Toxins. Band 8, Nr. 5, 3. Mai 2016, ISSN 2072-6651, S. 134, doi:10.3390/toxins8050134, PMID 27153087, PMC 4885049 (freier Volltext) – (mdpi.com [abgerufen am 28. Oktober 2023]).
  • Federica Tonon, Stefano Di Bella, Gabriele Grassi, Roberto Luzzati, Paolo Ascenzi, Alessandra di Masi, Cristina Zennaro: Extra-Intestinal Effects of C. difficile Toxin A and B: An In Vivo Study Using the Zebrafish Embryo Model. In: Cells. Band 9, Nr. 12, 1. Dezember 2020, ISSN 2073-4409, S. 2575, doi:10.3390/cells9122575, PMID 33271969, PMC 7760802 (freier Volltext) – (mdpi.com [abgerufen am 28. Oktober 2023]).
  • Deirdre A Collins, Thomas V. Riley: Ridinilazole: a novel, narrow‐spectrum antimicrobial agent targeting Clostridium ( Clostridioides ) difficile. In: Letters in Applied Microbiology. Band 75, Nr. 3, September 2022, ISSN 0266-8254, S. 526–536, doi:10.1111/lam.13664, PMID 35119124, PMC 9541751 (freier Volltext).
  • A. Howerton, M. Patra, E. Abel-Santos: A new strategy for the prevention of Clostridium difficile infection. In: The Journal of infectious diseases. Band 207, Nummer 10, Mai 2013, S. 1498–1504, ISSN 1537-6613. doi:10.1093/infdis/jit068. PMID 23420906.
  • Daniel Paredes-Sabja, Glenda Cofre-Araneda, Christian Brito-Silva, Marjorie Pizarro-Guajardo, Mahfuzur R. Sarker: Clostridium difficile Spore-Macrophage Interactions: Spore Survival. In: PLOS ONE. Band 7, Nr. 8, 27. August 2012, ISSN 1932-6203, S. e43635, doi:10.1371/journal.pone.0043635, PMID 22952726, PMC 3428350 (freier Volltext).

orf.at (Global: 418th place; German: 22nd place)

science.orf.at

oup.com (Global: 485th place; German: 715th place)

academic.oup.com

  • Thomas Jank, Torsten Giesemann, Klaus Aktories: Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. In: Glycobiology. Band 17, Nr. 4, 1. April 2007, ISSN 1460-2423, S. 15R–22R, doi:10.1093/glycob/cwm004 (oup.com [abgerufen am 4. Dezember 2020]).

redirecter.toolforge.org (Global: 33rd place; German: 2nd place)

rki.de (Global: 4,845th place; German: 310th place)

rki.de

edoc.rki.de

sachsen.de (Global: 2,508th place; German: 228th place)

revosax.sachsen.de

  • § 1 Abs. 1 Nr. 5 Sächsische Infektionsschutz-Meldeverordnung. Vollzitat: Sächsische Infektionsschutz-Meldeverordnung vom 19. Juli 2024 (SächsGVBl. S. 745). In: revosax.sachsen.de. Abgerufen am 22. Oktober 2024 (Fassung gültig ab: 17. August 2024).

sciencedirect.com (Global: 149th place; German: 298th place)

  • Klaus Aktories, Panagiotis Papatheodorou, Carsten Schwan: Binary Clostridium difficile toxin (CDT) – A virulence factor disturbing the cytoskeleton. In: Anaerobe (= ClostPath 2017: 10th International Conference on the Molecular Biology and Pathogenesis of the Clostridia). Band 53, 1. Oktober 2018, ISSN 1075-9964, S. 21–29, doi:10.1016/j.anaerobe.2018.03.001 (sciencedirect.com [abgerufen am 4. Dezember 2020]).

spiegel.de (Global: 66th place; German: 4th place)

theguardian.com (Global: 12th place; German: 25th place)

thelancet.com (Global: 2,393rd place; German: 2,660th place)

uni-koeln.de (Global: 2,455th place; German: 501st place)

portal.uni-koeln.de

web.archive.org (Global: 1st place; German: 1st place)

wissenschaft-online.de (Global: low place; German: 2,288th place)

zdb-katalog.de (Global: 123rd place; German: 6th place)

  • Michael B. Francis, Charlotte A. Allen, Ritu Shrestha, Joseph A. Sorg: Bile Acid Recognition by the Clostridium difficile Germinant Receptor, CspC, Is Important for Establishing Infection. In: PLOS Pathogens. Band 9, Nr. 5, 5. September 2013, ISSN 1553-7374, S. e1003356, doi:10.1371/journal.ppat.1003356, PMID 23675301, PMC 3649964 (freier Volltext).
  • Thomas Jank, Torsten Giesemann, Klaus Aktories: Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. In: Glycobiology. Band 17, Nr. 4, 1. April 2007, ISSN 1460-2423, S. 15R–22R, doi:10.1093/glycob/cwm004 (oup.com [abgerufen am 4. Dezember 2020]).
  • Stefano Di Bella, Paolo Ascenzi, Steven Siarakas, Nicola Petrosillo, Alessandra di Masi: Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects. In: Toxins. Band 8, Nr. 5, 3. Mai 2016, ISSN 2072-6651, S. 134, doi:10.3390/toxins8050134, PMID 27153087, PMC 4885049 (freier Volltext) – (mdpi.com [abgerufen am 28. Oktober 2023]).
  • Federica Tonon, Stefano Di Bella, Gabriele Grassi, Roberto Luzzati, Paolo Ascenzi, Alessandra di Masi, Cristina Zennaro: Extra-Intestinal Effects of C. difficile Toxin A and B: An In Vivo Study Using the Zebrafish Embryo Model. In: Cells. Band 9, Nr. 12, 1. Dezember 2020, ISSN 2073-4409, S. 2575, doi:10.3390/cells9122575, PMID 33271969, PMC 7760802 (freier Volltext) – (mdpi.com [abgerufen am 28. Oktober 2023]).
  • Klaus Aktories, Panagiotis Papatheodorou, Carsten Schwan: Binary Clostridium difficile toxin (CDT) – A virulence factor disturbing the cytoskeleton. In: Anaerobe (= ClostPath 2017: 10th International Conference on the Molecular Biology and Pathogenesis of the Clostridia). Band 53, 1. Oktober 2018, ISSN 1075-9964, S. 21–29, doi:10.1016/j.anaerobe.2018.03.001 (sciencedirect.com [abgerufen am 4. Dezember 2020]).
  • Keeley O’Grady, Daniel R. Knight, Thomas V. Riley: Antimicrobial resistance in Clostridioides difficile. In: European Journal of Clinical Microbiology & Infectious Diseases. Band 40, Nr. 12, 1. Dezember 2021, ISSN 1435-4373, S. 2459–2478, doi:10.1007/s10096-021-04311-5.
  • Deirdre A Collins, Thomas V. Riley: Ridinilazole: a novel, narrow‐spectrum antimicrobial agent targeting Clostridium ( Clostridioides ) difficile. In: Letters in Applied Microbiology. Band 75, Nr. 3, September 2022, ISSN 0266-8254, S. 526–536, doi:10.1111/lam.13664, PMID 35119124, PMC 9541751 (freier Volltext).
  • A. Howerton, M. Patra, E. Abel-Santos: A new strategy for the prevention of Clostridium difficile infection. In: The Journal of infectious diseases. Band 207, Nummer 10, Mai 2013, S. 1498–1504, ISSN 1537-6613. doi:10.1093/infdis/jit068. PMID 23420906.
  • Daniel Paredes-Sabja, Glenda Cofre-Araneda, Christian Brito-Silva, Marjorie Pizarro-Guajardo, Mahfuzur R. Sarker: Clostridium difficile Spore-Macrophage Interactions: Spore Survival. In: PLOS ONE. Band 7, Nr. 8, 27. August 2012, ISSN 1932-6203, S. e43635, doi:10.1371/journal.pone.0043635, PMID 22952726, PMC 3428350 (freier Volltext).